Skip to content
TrialScanner

NCT04488419

ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Phase 2/Phase 3CompletedLONALead

Registry record

Lead sponsor
LeonaBio
Conditions
Alzheimer Disease; Dementia of Alzheimer Type
Primary completion
Jul 15, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04488419 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04488419: ATH-1017 for Treatment of... | TrialScanner